Please login to the form below

Not currently logged in
Email:
Password:

Endo pain drug gets priority review

Endo Pharmaceuticals has been granted a priority review by the US Food and Drug Administration for a new formulation of its pain drug oxymorphone

Endo Pharmaceuticals has been granted a priority review by the US Food and Drug Administration (FDA) for a new formulation of its pain drug oxymorphone that is designed to prevent abuse.

The new tablet is made to resist crushing, breaking, powdering or pulverising.

Priority review, which is reserved for drugs that offer major advances in treatment or provide a treatment where no adequate therapy exists, means that the FDA aims to act on a New Drug Application (NDA) within six months rather than the standard 10 to 12 months. The FDA has set January 7, 2011 as the action date for the Endo product.

This new formulation of the long-acting drug is a semi-synthetic opioid analgesic for treatment of moderate-to-severe chronic pain in patients requiring continuous pain relief over an extended period of time.

Endo has marketed oxymorphone in the US since 1959. It sells the drug under the brandnames Opana and Opana ER.

23rd September 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics